IDH Results Presentation

November 2022

Contents:

  • IDH At a Glance
  • 9M 2022 Results Overview
  • Key Investment Highlights
    • Our Market
    • Our Business Model
    • Financial Position and Performance
    • Growth Strategies
    • Governance

Who We Are

Integrated Diagnostics Holding is a leading, fully-integrated provider of high-quality medical

diagnostic services with a footprint spanning Egypt, Jordan, Sudan and Nigeria

Our Services

Our Brands

Accreditations

Immunology Radiology Hematology

Endocrinology

Clinical

Molecular

Chemistry

Biology

Cytogenetics Histopathology Microbiology

+ 40 years

7 key brands

546

33.7 MN

21%

Hena Holdings

Track record

With strong awareness

Branch labs as at 30 Sep. 2022

FY21 Tests

Ltd

EGP 5.0BN

Shareholding 52%

+2,000

4

10.3 MN

Actis Idn B.V.

Structure

Free Float

Diagnostic tests

Country footprint (Egypt,

FY21 Patients

FY21 Net Sales

Jordan, Sudan & Nigeria)

27%

offered

3 INTEGRATED DIAGNOSTICS HOLDINGS

Our Geography

IDH currently operates the largest branch network amongst private providers in Egypt and boasts

an established presence in three key markets in the Middle East and Africa

Egypt

1979

496

#1

First began

Branches (49% in

Market Ranking1

(#1 in Corporate

operations

Cairo Region)

Insurance Sector)

82%

8.5 mn

29.7 mn

Share of

Patients served

Tests performed

consolidated net

in 2021

in 2021

sales in 9M 2022

Jordan

2011

21

#1

Acquisition of

Branches

Market Ranking1

Biolab

16%

1.6 mn

3.5 mn

Share of

Patients served

Tests performed

consolidated net

in 2021

in 2021

sales in 9M 2022

1 Market ranking amongst private players in each respective country.

Nigeria

2018

12

2%

Acquisition of

Share of

Branches

consolidated net

Echo Lab

sales in 9M 2022

153k

281k

Patients served

Tests performed

in 2021

in 2021

Sudan

2011

17

#1

First began

Branches

Market Ranking1

operations

1%

70k

182k

Share of

Patients served

Tests performed

consolidated net

in 2021

in 2021

sales in 9M 2022

4 INTEGRATED DIAGNOSTICS HOLDINGS

Our Patients

IDH serves two principal types of patients: contract and walk-in

Around 70% of total revenue generated across the two segments is paid in cash

Contract Patients

Walk-In Patients

IDH's contract clients include institutions who enter into one-year renewable contracts at agreed rates per-testand on a per-clientbasis. Around 40% of the revenue generated by the segment is paid in cash. IDH's corporate clients roster currently features institutions such as:

  • Unions

IDH's walk-in clients, also referred to as "self-payers",pay out of pocket for diagnostic tests and other services.

  • Syndicates
  • Private and public insurance companies
  • Banks and corporations
  • Public institutions

Contribution to IDH Net Sales (9M 2022)

Patient Split by Segment (9M 2022)

EGP

32%

42%

6.6 mn

2,737

58%

patients

mn

68%

Contract Revenues

Walk-in Revenues

Contract Patients

Walk-in Patients

5 INTEGRATED DIAGNOSTICS HOLDINGS

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

IDH - Integrated Diagnostics Holdings plc published this content on 24 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 November 2022 10:23:09 UTC.